Anticholesteremic Agents Market Size to Surpass US 1706 Billion by 2031 Growth Plus Reports

Newark, New Castle, USA, May 02, 2023 (GLOBE NEWSWIRE) — According to a recent Growth Plus Reports study, the anticholesteremic agents market was valued at US$ 12.52 billion in 2022. It is expected to register a revenue CAGR of 3.5% and reach US$ 17.06 billion by 2031. The study examines…Read More